O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-1.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.88B
AUM Growth
+$7.88B
(-24%)
Cap. Flow
-$1.99B
Cap. Flow
% of AUM
-25.25%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
148
New
11
Increased
16
Reduced
57
Closed
17
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$106M |
| 2 |
Amicus Therapeutics
FOLD
|
$80.2M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$77.8M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$43.5M |
| 5 |
scPharmaceuticals
SCPH
|
$41.2M |
Top Sells
| 1 |
Incyte
INCY
|
$172M |
| 2 |
AET
Aetna Inc
AET
|
$171M |
| 3 |
Biogen
BIIB
|
$127M |
| 4 |
Merck
MRK
|
$105M |
| 5 |
Gilead Sciences
GILD
|
$101M |
Sector Composition
| 1 | Healthcare | 91.38% |
| 2 | Financials | 1.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Intellia Therapeutics
NTLA
$1.22B
| $44.9M | 0.57% | 2,337,684 -324,496 | -12% | -$6.24M |
|
52
Iovance Biotherapeutics
IOVA
$807M
| $44.4M | 0.56% | 5,548,326 -877,300 | -14% | -$7.02M |
|
53
Stryker
SYK
$150B
| $44.3M | 0.56% | 286,000 -135,000 | -32% | -$20.9M |
|
54
KALA BIO
KALA
$78.8M
| $43.9M | 0.56% | 2,375,279 | – | – |
|
|
RDUS
55
DELISTED
Radius Health, Inc.
RDUS
| $43.6M | 0.55% | 1,371,700 +248,900 | +22% | +$7.91M |
|
|
56
Rhythm Pharmaceuticals
RYTM
$6.85B
| $43.5M | 0.55% | +2,901,295 | New | +$43.5M |
|
|
SHPG
57
DELISTED
Shire pic
SHPG
| $42.3M | 0.53% | 272,508 -127,400 | -32% | -$19.8M |
|
58
Bristol-Myers Squibb
BMY
$96B
| $42.2M | 0.53% | 688,000 -186,700 | -21% | -$11.4M |
|
|
AGN.PRA
59
DELISTED
Allergan plc.
AGN.PRA
| – | – | 0 | – | – |
|
|
60
scPharmaceuticals
SCPH
$295M
| $41.2M | 0.52% | +3,409,865 | New | +$41.2M |
|
|
61
Gilead Sciences
GILD
$140B
| $37.4M | 0.47% | 521,600 -1,406,400 | -73% | -$101M |
|
|
ALPN
62
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $36.9M | 0.47% | 3,298,516 | – | – |
|
63
Pfizer
PFE
$141B
| $35.6M | 0.45% | 982,000 -1,476,800 | -60% | -$53.5M |
|
64
DaVita
DVA
$9.85B
| $34.5M | 0.44% | +477,400 | New | +$34.5M |
|
65
Integra LifeSciences
IART
$1.18B
| $34.1M | 0.43% | 711,710 -379,200 | -35% | -$18.1M |
|
|
DERM
66
DELISTED
Dermira, Inc.
DERM
| $32.8M | 0.42% | 1,181,168 -237,705 | -17% | -$6.61M |
|
67
eHealth
EHTH
$118M
| $31.9M | 0.4% | 1,834,700 | – | – |
|
68
argenx
ARGX
$43.6B
| $31.6M | 0.4% | 500,000 | – | – |
|
|
EVHC
69
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $30.3M | 0.38% | 875,400 +434,700 | +99% | +$15M |
|
|
DCPH
70
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $26.7M | 0.34% | 1,176,070 +781,800 | +198% | +$17.7M |
|
71
Acadia Pharmaceuticals
ACAD
$4.38B
| $25.6M | 0.32% | +849,100 | New | +$25.6M |
|
|
OBSV
72
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $25.4M | 0.32% | 2,605,531 | – | – |
|
73
X4 Pharmaceuticals
XFOR
$84.3M
| $23.8M | 0.3% | +1,868,966 | New | +$23.8M |
|
|
ACHN
74
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $23.5M | 0.3% | 8,170,973 -4,891,927 | -37% | -$14.1M |
|
|
NBRV
75
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $23.4M | 0.3% | 3,919,600 | – | – |
|